MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — Defensive Interval Ratio

Latest as of September 2025: 21440 days

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a Defensive Interval Ratio of 21440 days as of September 2025. Defensive assets of $4.93 Million (cash $-, short-term investments $4.89 Million, receivables $35.44K) cover 21440 days of daily cash needs of $229.93/day. Check tangible equity quality of MIRA Pharmaceuticals, Inc. Common Stock to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

21440 days
Days of operational coverage

Defensive Assets

$4.93 Million
Cash + ST Investments + Receivables

Daily Cash Need

$229.93
Current Liabilities ÷ 365

Current Liabilities

$83.93K
USD

MIRA Pharmaceuticals, Inc. Common Stock Defensive Interval Ratio (2023–2023)

This chart shows how MIRA Pharmaceuticals, Inc. Common Stock's Defensive Interval Ratio has evolved across 1 annual periods from 2023 to 2023. As of September 2025, the ratio stands at 21440 days, meaning defensive assets of $4.93 Million can fund 21440 days of operations without new revenue. Also explore MIRA Pharmaceuticals, Inc. Common Stock (MIRA) net asset momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for MIRA Pharmaceuticals, Inc. Common Stock (2023–2023)

The table below presents the year-by-year Defensive Interval Ratio for MIRA Pharmaceuticals, Inc. Common Stock from 2023 to 2023, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MIRA Pharmaceuticals, Inc. Common Stock market capitalisation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2023 8 days $11.86K $1.53K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)